Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 5/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 7/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL385019 | 0.75 | ALDH1A1 (0.57) | UGT2B7TRPA1ALDH1A1TRPV1MEN1 | |
| SCHEMBL10101191 | 0.75 | ALDH1A1 (0.57) | UGT2B7TRPA1ALDH1A1TRPV1MEN1 | |
| SCHEMBL9880760 | 0.75 | ALDH1A1 (0.57) | UGT2B7TRPA1ALDH1A1TRPV1MEN1 | |
| SCHEMBL15886578 | 0.75 | ALDH1A1 (0.57) | UGT2B7TRPA1ALDH1A1TRPV1MEN1 | |
| SCHEMBL10601665 | 0.75 | UGT2B7 (0.31) | UGT2B7 | |
| SCHEMBL10674286 | 0.74 | ALDH1A1 (0.34) | TRPA1ALDH1A1TRPV1MEN1CYP3A4 | |
| SCHEMBL15061484 | 0.70 | UGT2B7 (0.33) | UGT2B7TRPA1ALDH1A1TRPV1MEN1 | |
| SCHEMBL5702612 | 0.69 | CYP3A4 (0.36) | TRPA1ALDH1A1CYP3A4MAPT | |
| SCHEMBL12468945 | 0.69 | CYP3A4 (0.32) | ALDH1A1CYP3A4MAPT | |
| SCHEMBL20568888 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2621995-B1 | ADVANCED EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-03-23 | — | — | EP | disclosed |
| US-9284434-B2 | Epoxy resin compositions | BLUE CUBE IP LLC (US) | 2016-03-15 | — | — | US | disclosed |
| EP-2621990-B1 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | BLUE CUBE IP LLC (US) | 2016-02-24 | — | — | EP | disclosed |
| US-9068039-B2 | Thermosettable compositions and thermosets therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-06-30 | — | — | US | disclosed |
| US-20150152285-A1 | ADVANCED EPOXY RESIN COMPOSITIONS | BLUE CUBE IP LLC | 2015-06-04 | — | — | US | disclosed |
| US-20140194554-A1 | EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-07-10 | — | — | US | disclosed |
| US-20130302336-A1 | DISULFIDE STABILIZED DVD-IG MOLECULES | UCB PHARMA S.A. (BE) | 2013-11-14 | — | — | US | disclosed |
| US-20130237642-A1 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-09-12 | — | — | US | disclosed |
| EP-2621995-A1 | ADVANCED EPOXY RESIN COMPOSITIONS | Dow Global Technologies LLC (US) | 2013-08-07 | — | — | EP | disclosed |
| EP-2621990-A2 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | Dow Global Technologies LLC (US) | 2013-08-07 | — | — | EP | disclosed |
| EP-2621994-A1 | EPOXY RESIN COMPOSITIONS | Dow Global Technologies LLC (US) | 2013-08-07 | — | — | EP | disclosed |
| US-20130178591-A1 | ADVANCED POLY EPOXY ESTER RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130178590-A1 | ADVANCED EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-07-11 | — | — | US | disclosed |
| WO-2012047420-A2 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-12 | — | — | WO | disclosed |
| WO-2012044458-A1 | ADVANCED EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-05 | — | — | WO | disclosed |
| WO-2012044443-A1 | EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-05 | — | — | WO | disclosed |
| US-20090306222-A1 | FOOD SUPPLEMENTS AND USES THEREOF | CHEMAPHOR INC. (CA) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130302336-A1 | DISULFIDE STABILIZED DVD-IG MOLECULES | EED, DRD2, PSMD14 | UGT2B7 1688/4885TRPA1 4784/4885ALDH1A1 1076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.